Modification of methodology results in improvement in simultaneous kidney-islet success

Transplant Proc. 1995 Feb;27(1):1349-50.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antilymphocyte Serum / therapeutic use
  • Azathioprine / therapeutic use
  • C-Peptide / blood
  • Cells, Cultured
  • Cyclosporine / therapeutic use
  • Diabetes Mellitus, Type 1 / therapy*
  • Diabetic Nephropathies / surgery*
  • Humans
  • Immunosuppression Therapy / methods
  • Islets of Langerhans
  • Islets of Langerhans Transplantation / immunology
  • Islets of Langerhans Transplantation / methods*
  • Islets of Langerhans Transplantation / physiology
  • Kidney Failure, Chronic / surgery*
  • Kidney Transplantation / immunology
  • Kidney Transplantation / methods*
  • Kidney Transplantation / physiology
  • Muromonab-CD3 / therapeutic use
  • Postoperative Complications
  • Prednisone / therapeutic use
  • Tissue Preservation
  • Transplantation, Heterotopic
  • Transplantation, Homologous

Substances

  • Antilymphocyte Serum
  • C-Peptide
  • Muromonab-CD3
  • Cyclosporine
  • Azathioprine
  • Prednisone